Status: Recruiting
Early Intervention in High Risk CCUS
This research is being done to find out more about the potential risks and benefits of early treatment in participants with high risk Clonal Cytopenia of Unknown Significance (CCUS). This study will give eligible CCUS participants the option of either being observed or taking an oral drug as treatment. The names of the study drug involved in this study is: -Decitabine/cedazuridine (DEC/CED) (a nucleoside metabolic inhibitor and cytidine deaminase inhibitor).
Participants needed: 108
Trial details
Phase: Early Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Lachelle D. Weeks, MD, PhDUpdated: Apr 23, 2026Locations: 1
Eligibility criteria
Age ≥18 years. [+12]
Concurrent primary malignancy requiring active cytotoxic chemotherapy and/or ion... [+11]